4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000950170-23-052710
Director acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Deshpande Milind Director | 2023-10-05 | Grant or award | +20,000 | 51,454 | D |
Loading xslF345X05/ownership.xml…